Gentherm expands its partnership with DUOMED to enhance patient temperature management solutions in France and Benelux.
Quiver AI Summary
Gentherm, a leader in thermal management technologies, has announced the expansion of its partnership with DUOMED into France, building on their successful collaboration in the Benelux region. This strategic move aims to enhance the availability of advanced patient temperature management technologies for healthcare providers across Europe. Under the agreement, DUOMED will distribute Gentherm's complete patient temperature management product lineup, including the Astopad® and Vytil-branded warming systems, in France and Benelux. Both companies emphasize their commitment to providing high-quality solutions that address regional healthcare needs, with positive feedback from French clinicians regarding the quality of the Vytil blankets. The partnership aligns with DUOMED's mission to connect healthcare professionals with innovative technologies, further solidifying both firms' commitment to improving patient care.
Potential Positives
- Expansion of partnership with DUOMED into France represents a strategic milestone, enhancing Gentherm's presence in the European healthcare market.
- Gentherm's full patient temperature management portfolio will be offered to healthcare providers in France, potentially increasing market share and sales.
- Positive early feedback from French clinicians regarding the quality of Gentherm's Vytil blankets underscores the company's commitment to product excellence and customer satisfaction.
- The partnership aligns with Gentherm's strategy to collaborate with market-leading partners who understand local healthcare needs, reinforcing their growth strategy in Europe.
Potential Negatives
- None
FAQ
What is the purpose of Gentherm's partnership with DUOMED?
The partnership aims to deliver advanced patient temperature management technologies to more clinicians and patients across Europe.
Which products will DUOMED offer in France?
DUOMED will offer Gentherm's Astopad® resistive warming system and Vytil-branded convective warming system in France and Benelux.
Why is DUOMED a suitable partner for Gentherm?
DUOMED has a strong presence in Europe and deep relationships with clinicians, which aligns with Gentherm's goals for expansion.
What feedback has been received from French clinicians?
French clinicians have provided positive feedback, particularly highlighting the superior quality of Vytil blankets compared to other options.
How does this partnership benefit healthcare professionals?
The partnership allows healthcare professionals access to high-quality, innovative medical technologies to improve patient care.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$THRM Insider Trading Activity
$THRM insiders have traded $THRM stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $THRM stock by insiders over the last 6 months:
- RONALD T HUNDZINSKI purchased 5,000 shares for an estimated $133,350
- WILLIAM T. PRESLEY (President & CEO) purchased 3,000 shares for an estimated $74,010
- KENNETH E WASHINGTON purchased 1,700 shares for an estimated $47,702
- THOMAS STOCKER (SVP, General Manager, Europe) has made 2 purchases buying 321 shares for an estimated $8,010 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$THRM Hedge Fund Activity
We have seen 112 institutional investors add shares of $THRM stock to their portfolio, and 130 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LOOMIS SAYLES & CO L P removed 560,593 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $22,381,675
- PEMBROKE MANAGEMENT, LTD removed 315,951 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $12,614,343
- RAYMOND JAMES FINANCIAL INC removed 236,296 shares (-61.3%) from their portfolio in Q1 2025, for an estimated $6,318,555
- TRIGRAN INVESTMENTS, INC. added 219,450 shares (+11.0%) to their portfolio in Q1 2025, for an estimated $5,868,093
- FMR LLC removed 218,569 shares (-41.2%) from their portfolio in Q1 2025, for an estimated $5,844,535
- LORD, ABBETT & CO. LLC removed 194,389 shares (-62.0%) from their portfolio in Q1 2025, for an estimated $5,197,961
- HITE HEDGE ASSET MANAGEMENT LLC removed 191,865 shares (-77.9%) from their portfolio in Q1 2025, for an estimated $5,130,470
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
NOVI, Mich., June 27, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM) a global market leader of innovative thermal management and pneumatic comfort technologies, today announced the expansion of its long-standing partnership with DUOMED into France. Building on years of successful collaboration in the Benelux region, this extension marks a strategic milestone as both companies work to deliver advanced patient temperature management technologies to more clinicians and patients across Europe.
Under this agreement, DUOMED will offer Gentherm’s full patient temperature management portfolio, including the Astopad ® resistive warming system, and the Vytil-branded convective warming system, manufactured by Gentherm, to healthcare providers in France and Benelux.
“It’s critical we work with market-leading partners who understand regional healthcare needs and can deliver local expertise,” said Steve Fletcher, Senior Vice President and General Manager, Medical. “DUOMED’s strong presence in Europe and deep relationships with clinicians make them a natural partner as we grow our footprint and reinforce our commitment to quality.”
The partnership also aligns closely with DUOMED’s mission to connect healthcare professionals with innovative medical technologies.
“Gentherm fits perfectly with our mission to deliver high-quality, end-to-end solutions that enable better care,” said Christian Defly, President, DUOMED France. “Their solutions complement our portfolio and offer the innovation, quality and reliability our customers expect. In fact, early feedback from French clinicians has been especially positive, with many highlighting the superior quality of Vytil blankets compared to other options on the market.” Gregoire Plessia, Director of the Vytil group at DUOMED added: “We are delighted to add the convective warming range, manufactured by Gentherm Medical, to our ever-growing range of Vytil branded products, which are known for delivering quality, safety and value for money to the end users.”
Gentherm Investor Contact
Gregory Blanchette
[email protected]
248.308.1702
Gentherm Media Contact
Melissa Fischer
[email protected]
248.289.9702
About Gentherm
Gentherm (NASDAQ: THRM) is a global market leader of innovative thermal management and pneumatic comfort technologies. Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, and Valve Systems. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities across 13 countries. In 2024, the company recorded annual sales of approximately $1.5 billion and secured $2.4 billion in automotive new business awards. For more information, go to www.gentherm.com.
About The DUOMED Group
The DUOMED Group, part of the Palex group, is a dynamic organization with a well-established reputation and is active in sales, consultancy, integration, training and technical support of medical technology and devices for hospitals and medical practices.
We are partnering with healthcare professionals and manufacturers of innovative medical technologies, to deliver high-quality end-to-end solutions that enable better care. For more information, visit https://www.duomed.com/fr-FR
About Vytil Products
Vytil have over 25 years of expertise in distribution of medical devices throughout Europe. Vytil products exceed expectations in terms of quality, safety, and value for money. Usability & innovation is at the center of everything they do. Vytil listens to the needs of their end-users & ensure they provide the medical community with best-in-class products. For more information, visit
https://www.duomed.com/en-GB/supplier-overview/vytil